Heidelberg Pharma AG Logo

Heidelberg Pharma AG

ISIN: DE000A11QVV0 | Ticker: HPHA | LEI: 391200E09XYBYITR1W32
Sector: Health Care – Sub-Industry: Pharmaceuticals
Country: Germany

About Heidelberg Pharma AG

Company Description

Heidelberg Pharma AG based in Ladenburg, Germany, is a biopharmaceutical company listed on the Frankfurt Stock Exchange in the Regulated Market / Prime Standard. The Company was founded in September 1997 by a team of physicians and oncologists from the Technical University of Munich. In 2000, the Company changed to an AG from a GmbH legal structure. In 2011, the subsidiary Heidelberg Pharma Research GmbH was acquired.
Heidelberg Pharma was restructured in 2014, which led to the discontinuation of all research and development activities in Munich. The shareholder’s meeting in July 2017 decided to move the registered office of WILEX AG from Munich to Ladenburg and to change the name of the Company to Heidelberg Pharma AG. The subsidiary Heidelberg Pharma GmbH is now named Heidelberg Pharma Research GmbH.

Year founded


Served area





Gregor-Mendel-Straße 22, 68526 Ladenburg – Germany

Filings & Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume
31.01.24 Pahl, Prof. Dr. Andreas Board Other EUR 0.00
18.12.23 Pahl, Prof. Dr. Andreas Board Buy EUR 10,130.00
13.10.22 4H invest GmbH Close relation Other EUR 993,666.24
13.10.22 Bohlini invest GmbH Close relation Other EUR 964,061.56
13.10.22 MH-LT-Investments GmbH Close relation Other EUR 506,241.96
13.10.22 Schneiders, Michael Board Buy EUR 13,088.40
13.10.22 Schneiders, Michael Board Buy EUR 4,895.60
07.09.22 Plate, Achim Board Buy EUR 30,869.92
06.09.22 Kudlek, Dr. Birgit Supervisory board Other EUR 7,496.16
22.03.22 4H invest GmbH Close relation Other EUR 0.00

Capital markets information






Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences





Designated Sponsor

Pareto Securities

Stifel Europe Bank AG

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.